학술논문

NSABP FB-13: An assessment of the biological and clinical effects of palbociclib with ovarian suppression and letrozole in the neoadjuvant treatment of pts (pts) with premenopausal (preM) estrogen-receptor positive/HER2-negative primary breast cancer
Document Type
Journal
Source
CANCER RESEARCH; FEB 2020, 80 4, 2p. Supplement: S
Subject
Language
English
ISSN
15387445